Terms: = Brain cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
28 results:
1. Upregulation of the oct3/4 Network in Basal Breast cancer Is Associated with Its Metastatic Potential and Shows Tissue Dependent Variability.
Rajan RG; Krutilina RI; Ignatova TN; Pavicevich ZS; Dulatova GM; Lane MA; Chatterjee AR; Rooney RJ; Antony M; Hagerty VR; Kukekov NV; Hanafy KA; Vrionis FD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298091
[TBL] [Abstract] [Full Text] [Related]
2. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract] [Full Text] [Related]
3. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
[TBL] [Abstract] [Full Text] [Related]
4. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract] [Full Text] [Related]
5. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and oct4 in human glioma.
Chen X; Yang F; Zhang T; Wang W; Xi W; Li Y; Zhang D; Huo Y; Zhang J; Yang A; Wang T
J Exp Clin Cancer Res; 2019 Feb; 38(1):99. PubMed ID: 30795814
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of expression of myogenin and oct4 in glioma.
Zheng N; Zhang D; Liu X
Minerva Pediatr (Torino); 2023 Aug; 75(4):544-549. PubMed ID: 30511560
[TBL] [Abstract] [Full Text] [Related]
7. Novel lncRNA-ZNF281 regulates cell growth, stemness and invasion of glioma stem-like U251s cells.
Li XT; Li JC; Feng M; Zhou YX; Du ZW
Neoplasma; 2019 Jan; 66(1):118-127. PubMed ID: 30509101
[TBL] [Abstract] [Full Text] [Related]
8. CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
Chen T; Chen J; Zhu Y; Li Y; Wang Y; Chen H; Wang J; Li X; Liu Y; Li B; Sun X; Ke Y
Oncogene; 2019 Feb; 38(8):1183-1199. PubMed ID: 30258108
[TBL] [Abstract] [Full Text] [Related]
9. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K
Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404
[TBL] [Abstract] [Full Text] [Related]
10. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract] [Full Text] [Related]
11. Expression and Prognostic Value of Oct-4 in Astrocytic brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract] [Full Text] [Related]
12. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models.
Dermawan JK; Hitomi M; Silver DJ; Wu Q; Sandlesh P; Sloan AE; Purmal AA; Gurova KV; Rich JN; Lathia JD; Stark GR; Venere M
Cancer Res; 2016 Apr; 76(8):2432-42. PubMed ID: 26921329
[TBL] [Abstract] [Full Text] [Related]
14. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
[TBL] [Abstract] [Full Text] [Related]
15. miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.
Kaid C; Silva PB; Cortez BA; Rodini CO; Semedo-Kuriki P; Okamoto OK
Cancer Sci; 2015 Sep; 106(9):1188-95. PubMed ID: 26250335
[TBL] [Abstract] [Full Text] [Related]
16. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
Al-Hussaini M; Dissi N; Souki C; Amayiri N
Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
[TBL] [Abstract] [Full Text] [Related]
17. Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
Santos MC; Silva PB; Rodini CO; Furukawa G; Marco Antonio DS; Zanotto-Filho A; Moreira JC; Okamoto OK
Stem Cells Dev; 2015 Nov; 24(22):2700-8. PubMed ID: 26159230
[TBL] [Abstract] [Full Text] [Related]
18. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract] [Full Text] [Related]
19. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
Lai IC; Shih PH; Yao CJ; Yeh CT; Wang-Peng J; Lui TN; Chuang SE; Hu TS; Lai TY; Lai GM
PLoS One; 2015; 10(3):e0114830. PubMed ID: 25763821
[TBL] [Abstract] [Full Text] [Related]
20. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.
Auffinger B; Tobias AL; Han Y; Lee G; Guo D; Dey M; Lesniak MS; Ahmed AU
Cell Death Differ; 2014 Jul; 21(7):1119-31. PubMed ID: 24608791
[TBL] [Abstract] [Full Text] [Related]
[Next]
